On the other hand, none of the other medications, such as lopinavir/ritonavir, interferon-β, ribavirin, enoxaparin, furosemide, and tocilizumab showed any association or protection with or against AKI development to staging I or II/III. This evidence concerns the gene PPIB and acute kidney injury.